NeuroMetrix Reports DPNCheck® Expansion in China
09 juil. 2020 13h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test...
NeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
25 juin 2020 13h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral...
NeuroMetrix to Target Chronic Knee Pain with Quell® 2.0 Wearable Pain Relief Device
10 juin 2020 13h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain. This effort includes...
NeuroMetrix Reports Q1 2020 Financial Results
23 avr. 2020 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. The Company is a leading...
NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia
16 avr. 2020 13h30 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic...
NeuroMetrix, Inc. Announces Date for First Quarter 2020 Financial Results Conference Call
16 avr. 2020 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 first quarter financial results before the opening of the market on...
NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only
10 avr. 2020 13h42 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., April 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that, due to the public health impact of the COVID-19 pandemic and in accordance with orders issued...
NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update
11 mars 2020 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell technology commercial strategy and pipeline. An estimated 100 million US...
NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®
05 mars 2020 12h14 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., March 05, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the recent publication of three additional DPNCheck clinical studies. DPNCheck is a point-of-care...
NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting
25 févr. 2020 13h58 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Feb. 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36th...